Raritan Pharmaceuticals DRxChoice Fiber Capsules Recall

Why it was recalled

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Product description

DRxChoice Fiber Capsules, 25 capsules per bottle, Psyllium Husk Fiber, Mfg. by Raritan Pharmaceuticals, East Brunswick, NJ, UPC 3-68163-11925-1.

Lot numbers, UPCs & expiration codes

Lots: 16274, Exp 06/15; 16471 Exp 08/15

Where it was sold

Nationwide

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-032-2013
Classification: Class II
Status: Terminated
Recall initiated: Sep 4, 2012
FDA report date: Oct 31, 2012
Quantity: 17,136 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Raritan Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-032-2013, exactly as published.

Show all FDA fields

City: East Brunswick
State: NJ
Status: Terminated
Country: United States
Event ID: 63384
Address: 8 Joanna Ct
Code information: Lots: 16274, Exp 06/15; 16471 Exp 08/15
Postal code: 08816-2108
Report date: Oct 31, 2012
Product type: Drugs
Recall number: D-032-2013
Classification: Class II
Recalling firm: Raritan Pharmaceuticals, Inc.
Product quantity: 17,136 bottles
Termination date: Oct 7, 2014
Reason for recall: Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.
Voluntary / mandated: Voluntary: Firm initiated
Product description: DRxChoice Fiber Capsules, 25 capsules per bottle, Psyllium Husk Fiber, Mfg. by Raritan Pharmaceuticals, East Brunswick, NJ, UPC 3-68163-11925-1.
Distribution pattern: Nationwide
Recall initiation date: Sep 4, 2012
Initial firm notification: E-Mail
Center classification date: Oct 25, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-032-2013, published Oct 31, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.